晚期肾病中冠心病的侵入性管理
综述聚焦晚期CKD患者冠心病的侵入性管理,深入讨论ISCHEMIA-CKD试验结果及其治疗启示。CKD改变传统风险因素效应,炎症和矿物质代谢异常起主导病理生理作用,传统风险模型和筛查试验在CKD人群表现较差,降脂治疗效力降低,侵入性治疗并发症更高。
要点
- CKD改变传统风险因素对动脉粥样硬化的影响,炎症和矿物质代谢异常起主导作用
- 传统风险模型和心血管筛查试验在CKD人群表现较差,降脂治疗效力降低
- CKD患者心脏缺血表现不典型,侵入性治疗并发症率高于肾功能正常或接近正常者
核心结论
- 综述深入讨论ISCHEMIA-CKD试验结果及其对晚期CKD冠心病侵入性治疗策略的启示。
研究设计与样本
- 综述,聚焦晚期CKD冠心病的侵入性管理,并简要讨论ESKD和肾移植受者的现有证据。
主要发现
- CKD改变传统风险因素对动脉粥样硬化的效应,炎症和矿物质代谢异常随肾功能下降起主导病理生理作用。
- 传统风险模型和心血管筛查试验在CKD人群表现相对较差,降脂治疗效力降低。
- CKD患者心脏缺血表现不典型,侵入性治疗并发症率高于肾功能正常或接近正常者。
临床怎么用
- 临床需认识CKD患者冠心病表现不典型及侵入性治疗并发症风险更高,结合ISCHEMIA-CKD结果权衡侵入性策略。
局限性
- CKD患者常被随机对照试验排除,现有证据存在缺口,需未来研究优先关注CKD人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Coronary artery disease (CAD) is highly prevalent in chronic kidney disease (CKD). CKD modifies the effects of traditional risk factors on atherosclerosis, with CKD-specific mechanisms, such as inflammation and altered mineral metabolism, playing a dominant pathophysiological role as kidney function declines. Traditional risk models and cardiovascular screening tests perform relatively poorly in the CKD population, and medical treatments including lipid-lowering therapies have reduced efficacy. Clinical presentation of cardiac ischemia in CKD is atypical, whereas invasive therapies are associated with higher rates of complications than in with patients with normal or near normal kidney function. The main focus of the present review is on the invasive approach to management of CAD in late-stage CKD, with an in-depth discussion of the findings of the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)-CKD trial, and their implications for therapeutic approach and future research in this area. We also briefly discuss the existing evidence in the epidemiology, pathogenesis, diagnosis, and medical management of CAD in late-stage CKD, end-stage kidney disease (ESKD), and kidney transplant recipients. We enumerate the evidence gap left by the frequent exclusion of patients with CKD from randomized controlled trials and highlight the priority areas for future research in the CKD population.
引用
- Karimi Galougahi K, Chadban S, Mehran R, et al. Invasive Management of Coronary Artery Disease in Advanced Renal Disease. Kidney Int Rep. 2021. PMID: 34169192. doi:10.1016/j.ekir.2021.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。